Theranostic role of MIBG in neuroblastoma
Aktolun, C.; Castellani, M.R.
Quarterly Journal of Nuclear Medicine and Molecular Imaging Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 3-5
2013
ISSN/ISBN: 1824-4785 PMID: 23474630 Document Number: 670553
Document emailed within 1 workday
Related Documents
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28Tsuchimochi, S.; Nakajo, M.; Nakabeppu, Y.; Tani, A. 1997: Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging Clinical Nuclear Medicine 22(10): 687-690
O'Donoghue, J.A.; Wheldon, T.E.; Babich, J.W.; Moyes, J.S.; Barrett, A.; Meller, S.T. 1991: Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma Progress in Clinical and Biological Research 366: 455-461
Rutgers, M.; Gubbels, A.A.; Hoefnagel, C.A.; Voûte, P.A.; Smets, L.A. 1991: A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy Progress in Clinical and Biological Research 366: 471-478
Lumbroso, J.D.; Guermazi, F.; Hartmann, O.; Coornaert, S.; Rabarison, Y.; Leclère, J.G.; Couanet, D.; Bayle, C.; Caillaud, J.M.; Lemerle, J. 1988: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Progress in Clinical and Biological Research 271: 689-705
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J. 1991: A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG) Progress in Clinical and Biological Research 366: 463-469
Samnick, S.; Kirsch, C.M. 1999: A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications Nuklearmedizin. Nuclear Medicine 38(7): 292-296
Shogase, T.; Shudo, H.; Nakai, Y.; Nagashima, K. 2000: A role of nuclear medicine in diagnosing cardiac disease--clinical use of 123I-BMIPP and 123I-MIBG Rinsho Byori. Japanese Journal of Clinical Pathology 48(2): 113-120
Ladenstein, R.; Chauvin, F.; Garaventa, A.; Bernard, J.L.; Zucker, J.M.; Lutz, P.; Bordigoni, P.; Plouvier, E.; Cahn, J.Y.; Frappaz, D. 1991: The role of BMT for neuroblastoma relapse patients. A report of the EBMT-STR Bone Marrow Transplantation 7 Suppl. 2: 90
Traber, J.; Fischer, K.; Latzin, S.; Hamprecht, B. 1975: Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma times glioma hybrid cells Nature 253(5487): 120-122
Andrich, M.P.; Shalaby-Rana, E.; Movassaghi, N.; Majd, M. 1996: The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma Pediatrics 97(2): 246-250
Baskin, F.; Carlin, S.C.; Kraus, P.; Friedkin, M.; Rosenberg, R.N. 1975: Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma Molecular Pharmacology 11(1): 105-117
Rubie, H.; Hartmann, O.; Giron, A.; Lemoine, G.; Guitard, J.; Robert, A.; Lemerle, J. 1990: Localized thoracic neuroblastoma: the role of surgery and therapeutic results. Apropos of 40 cases Chirurgie Pediatrique 31(3): 146-151
Kapelushnik, J.; Nagler, A.; Or, R.; Naparstek, E.; Cividalli, G.; Aker, M.; Mehta, J.; Mumcuoglu, M.; Slavin, S. 1993: Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging Transplantation Proceedings 25(3): 2375-2376
Lauro, G.; Businaro, R.; Butler, R.H.; Revoltella, R. 1980: Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells Journal of the National Cancer Institute 64(5): 1169-1172
Flux, G.D.; Chittenden, S.J.; Saran, F.; Gaze, M.N. 2011: Clinical applications of dosimetry for mIBG therapy Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(2): 116-125
Lumbroso, J.; Schlumberger, M. 1990: Clinical applications of radio-labelled mIBG La Revue du Praticien 40(2): 140-142
Elgazzar, A.H.; Gelfand, M.J.; Washburn, L.C.; Clark, J.; Nagaraj, N.; Cummings, D.; Hughes, J.; Maxon, H.R. 1995: I-123 MIBG scintigraphy in adults. A report of clinical experience Clinical Nuclear Medicine 20(2): 147-152
Gough, I.R.; Thompson, N.W.; Shapiro, B.; Sisson, J.C. 1985: Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas Surgery 98(1): 115-120
Rufini, V.; Troncone, L.; Valentini, A.L.; Danza, F.M. 1988: A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas La Radiologia Medica 76(5): 466-470